Digital PCR Quantification of a Circulating <i>RBP3</i> and <i>CRX</i> RNA Signature Establishes a Liquid Biopsy Framework for Precision Monitoring of Retinoblastoma. [PDF]
Mendes TB +7 more
europepmc +1 more source
Circulating miRNAs for glioblastoma monitoring: from biofluid to clinical decision. [PDF]
Leclerc A, Emery E, Levallet G.
europepmc +1 more source
Cancer in a Drop: Liquid biopsy insights from ESMO 2025. [PDF]
Maheswaran S +9 more
europepmc +1 more source
Clinician perspectives on the clinical utility of Belay Summit™ 2.0 cerebrospinal fluid test - A mixed methods study. [PDF]
Holdhoff M +8 more
europepmc +1 more source
Extracellular vesicle biomarkers: current status and future perspectives as novel tools in liquid biopsy. [PDF]
Huang W +12 more
europepmc +1 more source
Beyond the mutation: integrating radiogenomics, epigenetics, and immune signatures to overcome therapeutic resistance in CNS tumors: a narrative review. [PDF]
Beniwal SS +5 more
europepmc +1 more source
Clinical Utility of Belay Summit™ Cerebrospinal Fluid Test to Inform Diagnosis and Management of Central Nervous System Cancer-A Single Institution Case Series. [PDF]
Youssef M +16 more
europepmc +1 more source
Extracellular Vesicles in the Biology and Liquid Biopsy Diagnostics of Pediatric High-Grade Glioma - Emerging Findings and Opportunities. [PDF]
Jahouri S +6 more
europepmc +1 more source
Quantitative BRAF p.V600E mutation monitoring in cerebrospinal fluid cell-free DNA reflects therapeutic response to BRAF/MEK inhibitors in papillary craniopharyngioma: a report of two cases. [PDF]
Fudaba H +9 more
europepmc +1 more source
Long-read sequencing for cancer liquid biopsy: advancing precision oncology. [PDF]
Guzman G, Rodriguez A.
europepmc +1 more source

